Phthalates are ubiquitous in the built environment and are used across various fields, despite known endocrine disruptive properties, and other associated health hazards, including abnormalities in reproductive health and development. I investigated the presence of phthalates in the built environment using the Health Product Declaration (HPD) repository to survey for products containing these chemicals, investigated the literature for possible health effects and alternatives to phthalates, and conducted a laboratoy-based feasibility study of urinary biomarkers associated with phthalates using wastewater-based epidemiology (WBE) on a US university campus at the building-scale. Of the 5,278 products in the HPD repository, 73 contained phthalates and were most commonly found in windows, doors, flooring, sealants, insulations, and furnishings. Alternative plasticizers (cardanol, epoxidized soybean oil, hydrogenated castor oil) usage were identified in 10 products from HPD repository. The two wastewater samples analyzed by liquid chromatography-tandem mass spectrometry (LC-MS-MS) showed that dimethyl phthalate (DMP) was detectable, as well as its human metabolite, monomethyl phthalate (MMP), observed at a concentration of 163-202 ng/L. These results indicate low human exposure from the building materials in the limited convenience sample investigated. Future studies of building scale wastewater-based epidemiology are recommended to investigate these and other phthalates commonly found in the built environment, including diisononyl phthalate (DINP) and diisononyl hexahydrophthalate (DINCH).